本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Atara Biotherapeutics

7.60
+0.700010.14%
盤後7.600.00000.00%18:35 EDT
成交量:5.67萬
成交額:42.18萬
市值:4,452.77萬
市盈率:-0.67
高:7.76
開:6.97
低:6.94
收:6.90
資料載入中...

公司資料

公司名字:
Atara Biotherapeutics
交易所:
NASDAQ
成立時間:
2012
員工人數:
153
公司地址:
1280 Rancho Conejo Blvd,Thousand Oaks,California,United States
郵編:
91320
電話:
傳真:
- -
簡介:
Atara Biotherapeutics, Inc.於2012年8月22日在特拉華州成立。該公司是T細胞免疫療法的領導者,利用其新型同種異體EB病毒(EBV)T細胞平台為癌症和自身免疫性疾病患者開發轉化療法。

董事

名稱
職位
Pascal Touchon
Director,President and Chief Executive Officer
Ronald C. Renaud, Jr.
Chair of the Board
Ameet Mallik
Director
Beth Seidenberg
Director
Carol Gallagher
Director
Eric L. Dobmeier
Director
Maria Grazia Roncarolo
Director
Matthew K. Fust
Director
Roy Baynes
Director
William Heiden
Director

股東

名稱
職位
Pascal Touchon
Director,President and Chief Executive Officer
Amar Murugan
Senior Vice President, General Counsel
Kristin Yarema
Senior Vice President, Chief Commercial Officer
Utpal Koppikar
Executive Vice President, Chief Financial Officer
Jakob Dupont
Executive Vice President, Global Head of Research and Development